Showing results (291-300 of 391) with videos related to
Sort By:
Pageof 40
Head & Neck|July 15, 2010
Tumor volume as prognostic factor in chemoradiation for advanced head and neck cancerJoost L Knegjens, Michael Hauptmann, Frank A Pameijer, et al.Cancers|March 11, 2023
Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful WaitingManouk K Bos, Sarah R Verhoeff, Sjoukje F Oosting, et al.Targeted Oncology|July 21, 2019
Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus ExemestaneAnnelieke E C A B Willemsen, Jolien Tol, Nielka P van Erp, et al.BMC Plant Biology|April 9, 2009
Removing celiac disease-related gluten proteins from bread wheat while retaining technological properties: a study with Chinese Spring deletion linesHetty C van den Broeck, Teun W J M van Herpen, Cees Schuit, et al.Clinical and Experimental Immunology|December 12, 2024
Exploring the relation between TGF-β pathway activity and response to checkpoint inhibition in patients with metastatic melanomaStefan G van Ravensteijn, Avital L Amir, Daniele V F Tauriello, et al.Proceedings of the National Academy of Sciences of the United States of America|July 24, 2023
Photocatalytic chlorine atom production on mineral dust-sea spray aerosols over the North AtlanticMaarten M J W van Herpen, Qinyi Li, Alfonso Saiz-Lopez, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 5, 2020
Prospective practice survey of management of cetuximab-related skin reactionsR T Lugtenberg, C B Boers-Doets, P O Witteveen, et al.Ophthalmology|July 1, 2015
Serous Retinopathy Associated with Mitogen-Activated Protein Kinase Kinase Inhibition (Binimetinib) for Metastatic Cutaneous and Uveal MelanomaElon H C van Dijk, Carla M L van Herpen, Marina Marinkovic, et al.Inflammatory Bowel Diseases|September 28, 2019
Laryngeal Carcinoma in Patients With Inflammatory Bowel Disease: Clinical Outcomes and Risk FactorsSteffi E M van de Ven, Lauranne A A P Derikx, Iris D Nagtegaal, et al.Clinical Pharmacokinetics|October 28, 2018
Impact of CYP3A4*22 on Pazopanib Pharmacokinetics in Cancer PatientsSander Bins, Alwin D R Huitema, Pim Laven, et al.Pageof 40